These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 35834488

  • 21. Comparison of the in-vivo effect of two tranexamic acid doses on fibrinolysis parameters in adults undergoing valvular cardiac surgery with cardiopulmonary bypass - a pilot investigation.
    Zhou ZF, Zhai W, Yu LN, Sun K, Sun LH, Xing XF, Yan M.
    BMC Anesthesiol; 2021 Feb 02; 21(1):33. PubMed ID: 33530942
    [Abstract] [Full Text] [Related]

  • 22. Clinical trial on the effect of tranexamic acid on bleeding and fibrinolysis in primary hip and knee replacement.
    Alvarez J, Santiveri FJ, Ramos MI, Gallart L, Aguilera L, Puig-Verdie L.
    Rev Esp Anestesiol Reanim (Engl Ed); 2019 Feb 02; 66(6):299-306. PubMed ID: 30902396
    [Abstract] [Full Text] [Related]

  • 23. Plasmin thrombelastography rapidly identifies trauma patients at risk for massive transfusion, mortality, and hyperfibrinolysis: A diagnostic tool to resolve an international debate on tranexamic acid?
    Barrett CD, Moore HB, Vigneshwar N, Dhara S, Chandler J, Chapman MP, Sauaia A, Moore EE, Yaffe MB.
    J Trauma Acute Care Surg; 2020 Dec 02; 89(6):991-998. PubMed ID: 33230046
    [Abstract] [Full Text] [Related]

  • 24. Variable Response to Antifibrinolytics Correlates with Blood-loss and Transfusion in Posterior Spinal Fusion.
    Gibson BHY, Duvernay MT, McKeithan LJ, Benvenuti TA, Warhoover TA, Martus JE, Mencio GA, Emerson BR, Moore-Lotridge SN, Borst AJ, Schoenecker JG.
    Spine Deform; 2022 Jul 02; 10(4):841-851. PubMed ID: 35247191
    [Abstract] [Full Text] [Related]

  • 25. Tranexamic acid modulates the immune response and reduces postsurgical infection rates.
    Draxler DF, Yep K, Hanafi G, Winton A, Daglas M, Ho H, Sashindranath M, Wutzlhofer LM, Forbes A, Goncalves I, Tran HA, Wallace S, Plebanski M, Myles PS, Medcalf RL.
    Blood Adv; 2019 May 28; 3(10):1598-1609. PubMed ID: 31126915
    [Abstract] [Full Text] [Related]

  • 26. Tranexamic acid for trauma patients: a critical review of the literature.
    Cap AP, Baer DG, Orman JA, Aden J, Ryan K, Blackbourne LH.
    J Trauma; 2011 Jul 28; 71(1 Suppl):S9-14. PubMed ID: 21795884
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Tranexamic Acid Update in Trauma.
    Ramirez RJ, Spinella PC, Bochicchio GV.
    Crit Care Clin; 2017 Jan 28; 33(1):85-99. PubMed ID: 27894501
    [Abstract] [Full Text] [Related]

  • 29. Tranexamic acid dose-response relationship for antifibrinolysis in postpartum haemorrhage during Caesarean delivery: TRACES, a double-blind, placebo-controlled, multicentre, dose-ranging biomarker study.
    Ducloy-Bouthors AS, Gilliot S, Kyheng M, Faraoni D, Turbelin A, Keita-Meyer H, Rigouzzo A, Moyanotidou G, Constant B, Broisin F, Gouez AL, Favier R, Peynaud E, Ghesquiere L, Lebuffe G, Duhamel A, Allorge D, Susen S, Hennart B, Jeanpierre E, Odou P, TRACES working group.
    Br J Anaesth; 2022 Dec 28; 129(6):937-945. PubMed ID: 36243576
    [Abstract] [Full Text] [Related]

  • 30. Unravelling the Antifibrinolytic Mechanism of Action of the 1,2,3-Triazole Derivatives.
    Rabadà Y, Bosch-Sanz O, Biarnés X, Pedreño J, Caveda L, Sánchez-García D, Martorell J, Balcells M.
    Int J Mol Sci; 2024 Jun 26; 25(13):. PubMed ID: 39000111
    [Abstract] [Full Text] [Related]

  • 31. Influence of Tranexamic Acid on Inflammatory Signaling in Trauma.
    Barrett CD, Kong YW, Yaffe MB.
    Semin Thromb Hemost; 2020 Mar 26; 46(2):183-188. PubMed ID: 32160643
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator-induced hyperfibrinolysis in full-term pregnant women: a prospective interventional study.
    Lechien A, Faraoni D, Van der Linden P.
    Blood Coagul Fibrinolysis; 2021 Apr 01; 32(3):186-193. PubMed ID: 33470644
    [Abstract] [Full Text] [Related]

  • 34. Effects of tranexamic acid on coagulofibrinolytic markers during the early stage of severe trauma: A propensity score-matched analysis.
    Gando S, Shiraishi A, Wada T, Yamakawa K, Fujishima S, Saitoh D, Kushimoto S, Ogura H, Abe T, Mayumi T, Sasaki J, Kotani J, Takeyama N, Tsuruta R, Takuma K, Shiraishi SI, Shiino Y, Nakada TA, Okamoto K, Sakamoto Y, Hagiwara A, Fujimi S, Umemura Y, Otomo Y, JAAM FORECAST TRAUMA Study Group.
    Medicine (Baltimore); 2022 Aug 12; 101(32):e29711. PubMed ID: 35960088
    [Abstract] [Full Text] [Related]

  • 35. Tranexamic acid is associated with selective increase in inflammatory markers following total knee arthroplasty (TKA): a pilot study.
    Grant AL, Letson HL, Morris JL, McEwen P, Hazratwala K, Wilkinson M, Dobson GP.
    J Orthop Surg Res; 2018 Jun 18; 13(1):149. PubMed ID: 29914535
    [Abstract] [Full Text] [Related]

  • 36. Computational model of tranexamic acid on urokinase mediated fibrinolysis.
    Wu TB, Orfeo T, Moore HB, Sumislawski JJ, Cohen MJ, Petzold LR.
    PLoS One; 2020 Jun 18; 15(5):e0233640. PubMed ID: 32453766
    [Abstract] [Full Text] [Related]

  • 37. Fibrinolysis and tranexamic acid: mechanistic principles.
    Draxler DF, Medcalf RL.
    ANZ J Surg; 2020 Apr 18; 90(4):410-411. PubMed ID: 32339417
    [No Abstract] [Full Text] [Related]

  • 38. Biological mechanisms and individual variation in fibrinolysis after major trauma.
    Coats TJ, Morsy M.
    Emerg Med J; 2020 Mar 18; 37(3):135-140. PubMed ID: 32001608
    [Abstract] [Full Text] [Related]

  • 39. Double-blinded, placebo-controlled study of early tranexamic acid treatment in swine uncontrolled hemorrhage model.
    Sondeen JL, Hanson MA, Prince MD, de Guzman R, Polykratis IA, Aden JK, Cap AP, Dubick MA.
    J Trauma Acute Care Surg; 2016 Jan 18; 80(1):81-8. PubMed ID: 26683393
    [Abstract] [Full Text] [Related]

  • 40. Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study.
    Rozen L, Faraoni D, Sanchez Torres C, Willems A, Noubouossie DC, Barglazan D, Van der Linden P, Demulder A.
    Eur J Anaesthesiol; 2015 Dec 18; 32(12):844-50. PubMed ID: 26258658
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.